MedTrace Logo

CHOICES-TEEN Randomized Controlled Trial

NCT05368571 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-06-19

No results posted yet for this study

Summary

This randomized controlled trial will: 1) Test the efficacy of the CHOICES-TEEN (CT) intervention compared with an Attentional Control (AC) condition on reducing the risk of substance-exposed pregnancy (SEP) and HIV/STI among high-risk female youth involved with the juvenile justice system by reducing alcohol use, increasing marijuana cessation, reducing risk of pregnancy, and increasing condom use; 2) Test the efficacy of CT, compared to AC, on increasing cognitive self-regulation abilities; 3) Test proposed intervention mediators/mechanisms of action for CT overall and by race/ethnicity; and 4) Test the moderating effect of initial readiness to change on risk of SEP and risk of HIV/STI.

Conditions

  • Risk for an Alcohol-Exposed Pregnancy
  • Risk for Marijuana-Exposed Pregnancy
  • Risk for Substance-Exposed Pregnancy
  • HIV Risk
  • Sexually Transmitted Infection Risk

Interventions

OTHER

CHOICES-TEEN

This is a four-session hybrid in-person and Telehealth counseling intervention that is designed to reduce the risk of HIV/STI and alcohol- and marijuana-exposed pregnancy for young women who are involved in the juvenile justice system between the ages of 14-19.

OTHER

Health and Life Skills Education

This is a four-session psychoeducational intervention that is designed to provide information on time management, sleep, nutrition and exercise, and financial management.

Sponsors & Collaborators

  • Wayne State University

    collaborator OTHER

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Danielle E Parrish, Ph.D. · Baylor University

  • Kirk L von Sternberg, Ph.D. · University of Texas at Austin

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-08
Primary Completion
2026-04-10
Completion
2026-04-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05368571 on ClinicalTrials.gov